Bloomberg outage highlights another bank weakness

Bloomberg outage highlights another bank weakness
Bloomberg's global outage on Friday highlights yet another banking sector weakness. The financial data network's downtime may have been a problem only for the richest fraction of the top 1 percent. But it prompted enough worry for the Bank of England …
Read more on Reuters Blogs (blog)

Engineering humans: Utah professor joins group urging caution
"One of the concerns is that some people may want to use the technology to make trivial or cosmetic changes, rather than using it to prevent devastating diseases," said Carroll, distinguished professor of biochemistry at the University of Utah School …
Read more on Salt Lake Tribune

Nobel Prize winner Jack Szostak speaks at Auburn High School
Creating artificial cellular life might have been considered science fiction in the past, but such advances in biochemistry could be significant for in the fight against cancer and in slowing the aging process. Dr. Jack Szostak, professor of genetics …
Read more on Opelika Auburn News

Researchers study early response of cells to ischemia

Researchers study early response of cells to ischemia
In particular, we used the ribosome profiling technique which allows the capture of a "snapshot" of all protein synthesis in the cell at a given time. The protein synthesis in the cell is driven by ribosomes, which are huge macromolecular machines …
Read more on News-Medical.net

EFSA publishes draft magnesium intakes opinion – calls for input
Magnesium has won claims under the EU nutrition and claims regulation (NHCR) for the maintenance of normal bone, teeth, and protein synthesis; the reduction of tiredness and fatigue; electrolyte balance; normal energy-yielding metabolism; …
Read more on NutraIngredients.com

Researchers Discover Mitochondrial Mutation That Leads to Fatty Liver Disease
In a new study entitled “Mutation in MRPS34 Compromises Protein Synthesis and Causes Mitochondrial Dysfunction,” researchers discovered a mutation in a mitochondrial ribosome that induces mitochondria dysfunction leading to heart hypertrophy and liver …
Read more on Mitochondrial Disease News

Women in science: A perspective from Peru

Women in science: A perspective from Peru
Dionicia Gamboa is a winner of the 2013 Elsevier Foundation Awards for Early Career Women Scientists in the Developing World. For International Women's Day, we asked her to tell us about what inspired her to become a scientist, and her perspective on …
Read more on BMC Pediatrics (blog)

Elsevier to publish the official journal of the Society for Investigative
Elsevier, a world-leading provider of scientific, technical and medical information products and services and the Society for Investigative Dermatology (SID) have announced that they have entered into a publishing agreement . Beginning in January 2016 …
Read more on Phys.Org

Public Release: 3-Mar-2015 A high-salt diet could protect against invading
Most people consume more salt than they need and therefore have a higher risk of heart disease and stroke, which are the two leading causes of death worldwide. But a study published by Cell Press March 3rd in Cell Metabolism reveals that dietary salt …
Read more on EurekAlert (press release)

Ice Flaker Machine or supreme quality ice making equipments

The ice flaker machines are an absolute necessity for our blood banks and hospitals dealing with routine blood and tissue samples and research laboratories carrying out genetic testing, molecular biology, and biochemistry and biotechnology experiments. They serve as effective tools for biosynthesis and chemosynthesis experiments by maintaining the reaction rate through effective temperature regulation and are also used in bakeries and other food industries as the most ideal temperature controlling equipments. The ice flaker machines also find use inthe fishing industry for faster cooling of the sea food and other sea products to keep them fresh for long and in the food processing industries to cool the processed foods while still retaining the moisture within.

The Ice flaker machine is basically used to make flake ice, a type of dry, non-sticky ice used extensively in research laboratories, pharmaceutical industries, food industries and construction sites for cooling processes due to its outstanding refrigerating effect. The Flake ice is made from a mixture of brine and water and is characterized by a flat and thin shape for increased area of contact that allowsrapid heat exchange and faster cooling of the contact material. It is used for storage and transport of biological samples requiring preservation at low temperatures and for cooling of food items and concrete used for construction of buildings and infrastructure.

The ice flaker machines generally require a very less start-up time of around 10-15 minutes to start the production of initial batches of ice flakes and are designed for continuous production with an easy extraction system for ease of use. The machines are equipped with a storage bin of appropriate storage capacity to meet the requirements of the industry and an automatic cut off system that signals the machine to cease ice production when the storage bin is full. The ice flaker machines are also equipped with other safety features such as an automatic cut off system for low water level and a geared motor to protect the machine from overheating and high voltage.

These ice flaker machines use microprocessor based controls for temperature that are highly accurate and user friendly. The equipment has a very sturdy construction with highly resistant, corrosion proof external and internal surfaces that protect it from rusting and corrosion due to constant exposure to water and air. The ice flaker machine uses environmental friendly CFC free cooling for better energy efficiency and effective PUF insulation that protects the machine from temperature fluctuations.

The ice flaker machines are available in both standard and customized models to meet individual customer specifications and are quite light in weight for ease of portability. Most of the models are also equipped with castor wheels for easy movement. They are available in various sizes in visually appealing and pleasant designs that complement the overall look of the equipment while retaining the functionality and ease of operation.

Rodsi Bhatia is great author. She writes article for Laboratory and Educational Scientific Equipment , Lab oven, Test chamber and Deep Freezer . You can also find the more information about these equipments Log on to acmasindia.com.

Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz


Woodbridge, NJ (PRWEB) February 26, 2015

On behalf of biotech client GenScript USA, Inc. and its affiliated companies, Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured a significant jury verdict in a trade secrets lawsuit against Genewiz Inc. in excess of $ 10 million. The jury determined that Genewiz illegally obtained and utilized GenScript’s trade secrets, and that it improperly hired one or more of GenScript’s employees. The court entered an order denying motions for judgment notwithstanding the verdict, a new trial, and remittitur.

The case rested on allegations that the defendants stole confidential procedures GenScript developed for gene synthesis. A critical–and potentially life-saving–tool in DNA technology, gene synthesis has been a foundation of GenScript’s business for many years, leading to its recognition as a worldwide leader in the industry. The technologies have revolutionized scientific research in areas such as vaccine and other pharmaceutical development and the production of sustainable biofuels.

“This important victory for GenScript sends a strong reminder that there are rules for fair competition and they will be enforced. Companies like GenScript that take precautions to protect their trade secrets have a remedy if and when employees or competitors illegally threaten their business,” remarked Willard Shih of Wilentz, who led the firm’s trial team. “The jury grasped the central issue,” Shih added, “which is that trade secrets are some of the most critical corporate assets that the law protects.”

“We are pleased with the outcome of this case,” GenScript’s Chairman of the Board and CEO Frank Zhang stated. “While the trial was long and hard fought, I applaud the jury for recognizing that GenScript’s methods to synthesize genes are trade secrets that provide it with a competitive advantage.”

The case GenScript USA, Inc. et al. v. Genewiz Inc. and Ping Yang (Superior Court of New Jersey, Middlesex County, Law Division, Docket No. MID-L-6640-11 and MID-L-1739-13 (consolidated), began in 2011. Testimony was taken in two continents, culminating with a six-week trial presided over by the Honorable Arthur Bergman.

About Wilentz, Goldman & Spitzer, P.A.

Established in 1919, Wilentz, Goldman & Spitzer, P.A. combines the talents of 120 attorneys, serving the needs of prominent corporate and not-for-profit institutions. The firm’s litigation team has been at the forefront of numerous landmark cases and precedent-setting decisions. Wilentz maintains offices in in Woodbridge and Eatontown, N J, New York City, and Philadelphia. For more information about the firm, visit http://www.wilentz.com.

About GenScript USA

Based in Piscataway, New Jersey, Genscript is a leading gene, peptide, protein and antibody research partner for fundamental life science research, translational biomedical research, and early stage pharmaceutical development. Since its establishment in 2002, GenScript has grown into a global Contract Research Organization that provides services and products to scientists in 86 countries worldwide. The company has built a best-in-class capacity and capability for biological research services encompassing gene synthesis and molecular biology, peptide synthesis, custom antibodies, protein expression, antibody and protein engineering, and in vitro and in vivo pharmacology. For more information, see http://www.genscript.com.







Dr. S.K. Dash, Chairman & Founder of UAS Laboratories, LLC and President of DD Innovations, Inc., Received Highest Academic Honor

gI_60555_20150227_101050


Edina, MN (PRWEB) March 13, 2015

Dr. Sita Kantha Dash

Occupation: Innovator; Entrepreneur; Philanthropist

Born: Cuttack, Odisha, November 15, 1942

Education:

Ph.D. (Nutrition & Biochemistry), South Dakota State University, Brookings, South Dakota (USA) 1973

MS (Nutrition), South Dakota State University, Brookings, South Dakota (USA) 1970

Career

Chairman and Founder, UAS Laboratories, LLC. Wausau, WI (USA), April 2013-Present; President & Founder, DD Innovations, Inc., Edina, Minnesota (USA) January 2014 – Present; President , UAS Laboratories, Inc. Minneapolis, Minnesota (USA) 1979- April 2013; President, APN Laboratories, Inc. Wisconsin (USA) 2010-2013; Director, Food and Drug, South Dakota, (USA) 1973- 81; Adjunct Professor, Dept of Health & Nutritional Sciences, South Dakota State University, 2011-Present; Adjunct Professor, Department of Health Science, Minnesota State University, Minnesota (USA) 1991-1992; Vice President & Director, International Probiotics Association 2008-2011; Chairman, Kalinga HCO Foundation 2008- Present.

Career Related

Director, Kalinga Hospital; Director, Hospital Corporation of Odisha; President, Odisha Society of Americas; Director, International Probiotics Association; Chairman, Hindu Society of Minnesota; Chairman, Kalinga HCO foundation; Director, India Association of Minnesota; Chairman, Dr. Dash Foundation.

Innovative Works

Introduced acid-resistant, non-dairy probiotics in USA; Introduced quality control (CFU/g) standards for probiotics worldwide; Expanded consumer awareness on probiotics in USA that has grown from 5% ten years ago to 85% now and helped increase probiotics market from 10 million dollars to 32 billion dollars today. Developed and marketed most stable and effective probiotic strains Lactobacillus acidophilus DDS®-1 and other strain like Lactobacillus plantarum 2B . Innovator of clinically tested probiotic products – Probioplus DDS, DDS-Acidophilus, DDS-Plus, DDS-Junior and Cran-Gyn DDS. Inventor of “Method of preventing, Controlling and ameliorating Urinary tract infections and supporting digestive health by using synergistic Cranberry derivative, A D-Mannose composition and a proprietary probiotic blend with US Patent #12/889,450 (Pending).

Civic

Established Dr. S. K. Dash Probiotic & Prebiotic Innovation Center for Excellence and Endowed Professorship at Indian Institute of Technology (IIT), Bhubaneswar, India and South Dakota State University, Brookings, South Dakota, USA 2014; Helped in establishing Non Resident Oriya Facilitation center (NROFC), Bhubaneswar, India; Helped in establishing Kalinga Hospital in Odisha ; Helped in setting up Fakir Mohan University in Odisha ; Helped in setting up Regional Blood Bank in Bhubaneswar; Helped in setting up four Odisha -America Resource centers in Odisha; Provide scholarships to students of Odisha State, South Dakota State University and South Dakota School of Mines; Helped in setting up Urgent Care health center in Cuttack, India; Adopted a village, three orphanages, four high schools in Odisha, India. Set up a Polytechnic Institute for under privileged students in Odisha, India. Founding member and president, Odisha Society of Americas 1993-1995; Chairman, Hindu Society of Minnesota 1996-98; Sponsored areas- Literature & Education (Pratibha Ray, Monoj Das, Chandrasekhar Rath, Bibhuti Patnaik and others); Art and Music (Prafulla Kar, Sikander Alam, Pranab Patnaik, Akshaya Mohanty, Raghunath Panigrahi and others), Dance (Sanjukta Panigrahi, Kelucharan Mohapatra, Gangadhar Pradhan, Aruna Mohanty, Kavita Diwedi and others); Mount Everest climber, Former President of India Dr. Abdul Kalam to Minneapolis and many others.

Awards and Honors

Recipient “Distinguished Alumni Award”, South Dakota State University 2014; Recipient “2010 Probiotic Award”, Frost & Sullivan; Recipient “Minnesota Indo-American Association Achievement Award” 2009; Honored “Probiotic Prophet”, Healthy Living Consumer Magazine 2009; Honored “Minnesota State Senate” 2007; Recipient “Distinguished Non Resident Oriya” Government of Odisha (NROFC) 2006; Recipient “Prabasi Utkal Sanman”. “Outstanding man of the year” Odisha Society of Americas 2000; “Outstanding man of the year” Hindu Society of Minnesota 1998; Recipient “Distinguished Alumni Award”, Ch. R.N. Bidyapitha, Cuttack, India 2001; Recipient “Best of Eden Prairie Award”, U.S. Commerce Association 2009 – 2012; Recipient “Golden Arch Award”, NRI Institute for Innovation in Probiotics and medicine 1991; “Man of the year”, American Biographical Institute 1998; “Lion of the Year”, Capital Lions Club of Pierre, South Dakota 1977; Listed in who’s who in the world, who’s who in Midwest (USA) and National registry of Who’s who. Innovator and Entrepreneur nominee of America 1995.

Membership

Sigma Xi, The Scientific Research Society of North America; American Association for Advancement of Science; American Association of Pharmaceutical Scientists; Institute of Food Technologists; Natural Product Association; American College of Advancement of Medicine; American Veterinary Medical Association; American Dairy Science Association; American Society of Animal Science; Council of Agricultural Science and Technology; South Dakota Academy of Science; New York Academy of Science; American College of Nutrition; The Collaborative Group; The Indus Entrepreneurs (TiE), Minnesota Chapter; Academy of Nutrition and Dietietics, Minnesota Chapter; Edina Chamber of Commerce.

Family

Son of Nila Kantha and Duti Dash; Married Kalpana Dash, June 18, 1967; Children: Raj Dash (Son) and Kelly (Daughter-in-Law); Dave Dash (Son) and Katie (Daughter-in-Law).

Address

Home: 4925 Interlachen Court, Edina, MN 55436, USA







Stevens Institute of Technology Receives $251,000 Instrumentation Donation from Merc

Hoboken, NJ (PRWEB) December 18, 2014

Instruments will aide in the study of new drug discovery

The Center for Healthcare Innovation at Stevens Institute of Technology has received a donation of laboratory instruments, valued at more than $ 251,500, to establish a new Biophysical Chemistry Laboratory within the Biotechnology and Drug Discovery Laboratory aimed at exposing students to biotechnology and drug development. Preclinical drug discovery is the first step toward the development of new medications for the treatment of a variety of diseases.

Merck, a global healthcare leader, donated both large and small pieces of equipment that were no longer being utilized. The donated items include fluorescence plate readers, a spectropolarimeter, and isothermal titration calorimeter which will allow students to develop their biochemistry and biophysical chemistry expertise in enzyme kinetics and drug binding. Had the instruments been purchased at their original retail price, the cost would be more than $ 600,000.

“This donation will give Stevens more competencies to train our students in more detailed aspects of drug discovery and development,” says Dr. Peter Tolias, Professor and Director of the Center for Healthcare Innovation. “Furthermore, the gift provides new resources for the faculty, and affords an opportunity to move forward with our drug discovery projects.”

The instruments were delivered by Merck in late October and are currently in place to assist with the development of biological and chemically-based drugs.

“These instruments will be useful in our research to confirm the activity of newly discovered drugs and to understand how the drugs bind and inhibit the function of proteins involved in causing disease,” said Dr. William Windsor, Director of the Biophysical Chemistry Laboratory. “Ultimately, we would also like to develop a course that incorporates the new lab for students to conduct research and receive credit.”

The Biotechnology and Drug-Discovery Laboratory opened in January 2014 as a new biotechnology and drug discovery enterprise that partners with other Stevens faculty, students and external academic and industry collaborators.

About the Stevens Center for Healthcare Innovation

The Stevens Center for Healthcare Innovation seeks solutions to improve medical technology and healthcare delivery through education and research, connecting the fields of medicine, engineering and science by sponsoring research, building partnerships, commercializing intellectual property and creating curricula to strengthen skill gaps in the workforce. Over 60 university faculty from diverse academic disciplines are affiliated with the Center for Healthcare Innovation, tackling unmet needs in medical technology and major issues in healthcare delivery with their students. Current areas of research include tissue engineering of cancer biopsies for drug assessment and therapy selection, biomaterials that promote cell growth and control infection in implanted prosthetic and medical devices, drug discovery and development initiatives, mobile healthcare and telemedicine applications, and data analytics and modeling of healthcare delivery systems. Additional information can be obtained at the Center for Healthcare Innovation website at http://www.stevens.edu/chi or by contacting the center’s director at ptolias(at)stevens(dot)edu.

About Stevens Institute of Technology

Stevens Institute of Technology, The Innovation University®, is a premier, private research university situated in Hoboken, N.J. overlooking the Manhattan skyline. Founded in 1870, technological innovation has been the hallmark and legacy of Stevens’ education and research programs for more than 140 years. Within the university’s three schools and one college, more than 6,800 undergraduate and graduate students collaborate with more than 380 faculty members in an interdisciplinary, student-centric, entrepreneurial environment to advance the frontiers of science and leverage technology to confront global challenges. Stevens is home to four national research centers of excellence, as well as joint research programs focused on critical industries such as healthcare, energy, finance, defense, maritime security, STEM education and coastal sustainability. The university is consistently ranked among the nation’s elite for return on investment for students, career services programs and mid-career salaries of alumni. Stevens is in the midst of a 10-year strategic plan, The Future. Ours to Create., designed to further extend the Stevens legacy to create a forward-looking and far-reaching institution with global impact.